United States (US) Therapeutic Vaccines Market (2026-2032) | Competitive Landscape, Segmentation, Analysis, Companies, Forecast, Outlook, Growth, Value, Size & Revenue, Trends, Industry, Share

Name: United States (US) Therapeutic Vaccines Market | Size 2032
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Peptide Therapeutic Vaccine, Cell Therapeutic Vaccine, Nucleic Acid Therapeutic Vaccine), By Therapeutic Vaccines (Oncotherapy, Hepatitis B, Tuberculosis, Herpes Simplex Virus, Others) And Competitive Landscape

Product Code: ETC9977991	Publication Date: Sep 2024	Updated Date: Apr 2026	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

United States (US) Therapeutic Vaccines Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, the United States imported therapeutic vaccines primarily from Austria, Metropolitan France, Italy, Germany, and Brazil. The market shows low concentration with a low Herfindahl-Hirschman Index (HHI) indicating a competitive landscape. However, the industry experienced a significant decline with a Compound Annual Growth Rate (CAGR) of -31.87% from 2020 to 2024. The negative growth trend continued in 2024 with a rate of -39.06%, highlighting challenges and potential shifts in the therapeutic vaccines import market dynamics.

United States (US) Therapeutic Vaccines Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

United States (US) Therapeutic Vaccines Market Outlook
Market Size of United States (US) Therapeutic Vaccines Market, 2025
Forecast of United States (US) Therapeutic Vaccines Market, 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Revenues & Volume for the Period 2022 - 2032
United States (US) Therapeutic Vaccines Market Trend Evolution
United States (US) Therapeutic Vaccines Market Drivers and Challenges
United States (US) Therapeutic Vaccines Price Trends
United States (US) Therapeutic Vaccines Porter's Five Forces
United States (US) Therapeutic Vaccines Industry Life Cycle
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Type for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Peptide Therapeutic Vaccine for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Cell Therapeutic Vaccine for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Nucleic Acid Therapeutic Vaccine for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Therapeutic Vaccines for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Oncotherapy for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Hepatitis B for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Tuberculosis for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Herpes Simplex Virus for the Period 2022 - 2032
Historical Data and Forecast of United States (US) Therapeutic Vaccines Market Revenues & Volume By Others for the Period 2022 - 2032
United States (US) Therapeutic Vaccines Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Therapeutic Vaccines
United States (US) Therapeutic Vaccines Top Companies Market Share
United States (US) Therapeutic Vaccines Competitive Benchmarking By Technical and Operational Parameters
United States (US) Therapeutic Vaccines Company Profiles
United States (US) Therapeutic Vaccines Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Therapeutic Vaccines Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F

3.3 United States (US) Therapeutic Vaccines Market - Industry Life Cycle

3.4 United States (US) Therapeutic Vaccines Market - Porter's Five Forces

3.5 United States (US) Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F

3.6 United States (US) Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F

4 United States (US) Therapeutic Vaccines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the US, driving the demand for therapeutic vaccines.

4.2.2 Growing focus on preventive healthcare and vaccination programs by the US government and healthcare providers.

4.2.3 Technological advancements in vaccine development leading to more effective therapeutic vaccines.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines in the US.

4.3.2 High costs associated with the development and production of therapeutic vaccines.

4.3.3 Limited awareness and understanding of therapeutic vaccines among healthcare professionals and patients.

5 United States (US) Therapeutic Vaccines Market Trends

6 United States (US) Therapeutic Vaccines Market, By Types

6.1 United States (US) Therapeutic Vaccines Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F

6.1.3 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F

6.1.4 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F

6.1.5 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F

6.2 United States (US) Therapeutic Vaccines Market, By Therapeutic Vaccines

6.2.1 Overview and Analysis

6.2.2 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F

6.2.3 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F

6.2.4 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F

6.2.5 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F

6.2.6 United States (US) Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F

7 United States (US) Therapeutic Vaccines Market Import-Export Trade Statistics

7.1 United States (US) Therapeutic Vaccines Market Export to Major Countries

7.2 United States (US) Therapeutic Vaccines Market Imports from Major Countries

8 United States (US) Therapeutic Vaccines Market Key Performance Indicators

8.1 Patient engagement and adherence rates to therapeutic vaccine regimens.

8.2 Clinical trial success rates for new therapeutic vaccines.

8.3 Adoption rates of therapeutic vaccines in targeted patient populations.

9 United States (US) Therapeutic Vaccines Market - Opportunity Assessment

9.1 United States (US) Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F

9.2 United States (US) Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F

10 United States (US) Therapeutic Vaccines Market - Competitive Landscape

10.1 United States (US) Therapeutic Vaccines Market Revenue Share, By Companies, 2025

10.2 United States (US) Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Therapeutic Vaccines Market

Eritrea Therapeutic Vaccines Market

Estonia Therapeutic Vaccines Market

Ethiopia Therapeutic Vaccines Market

Fiji Therapeutic Vaccines Market

Finland Therapeutic Vaccines Market

Global Therapeutic Vaccines Market

Middle East Therapeutic Vaccines Market

North America Therapeutic Vaccines Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here